5Muir T, Kirsten M, Fourie P, et al. Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations[J]. Pediatr Surg Int, 2004,19:766-773.
6Zhi K, Wen Y, Li L, et al. The role of intralesional Pingyangmycin in the treatment of venous malformation of facial and maxillary region[J]. Int J Pediatr Otorhinolaryngol, 2008,72(5):593-597.
7Zhao JH, Zhang WF, Zhao YF. Sclerotherapy of oral and facial venous malformations with use of piugyangmycin and/or sodium morrhuate[J]. Int J Oral Maxillofac Surg, 2004, 33:463-466.
8Sung MW, Chang SO, Choi JH, et al. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck[J]. Am J Otolaryngol, 1995, 16(4):236-241.
9Martìn-Padura I,De Castellarnau C,Uccini S,et al.Expression of VE (vascular endothelial) -cadherin and other endothelial-specific markers in haemangiomas.J Pathol,1995,175(1):51-57.
10Takaha S,Mulliken J B,Kozakewich H P,et al.Cellular markers that distinguish the hase of hemangiomas during infancy and childhood.J Clin lnuest,1994,93(15):2357-2368.
2(Division of Vascular Anomalies,Chinese Society of Oral and Maxillofacial Surgery,Chinese Stomatological Association.China).平阳霉素治疗脉管性疾病规范[J].中国口腔颌面外科杂志,2011,9(1):68-69. 被引量：43
